title: Targeting α-Synuclein as a therapy for Parkinson's disease: The battle begins.
authors.affiliation: Departments of Neurology and Neuroscience, Mount Sinai School of Medicine, New York 10029, New York, USA.|Clintrex LLC.
authors.forename: C Warren
authors.initials: CW
authors.lastname: Olanow
authors.affiliation: Department of Neurological Sciencs, Rush University Schoolf of Medicine, Chicago, Illinois, USA.|Van Andel Research Institute, Grands Rapids Michigan 60612, USA.
authors.forename: Jeffrey H
authors.initials: JH
authors.lastname: Kordower
mesh_terms: D006801:Humans; D009474:Neurons; D010300:Parkinson Disease; D013378:Substantia Nigra; D051844:alpha-Synuclein
chemical_list: D051844:alpha-Synuclein